Page last updated: 2024-10-24

celiprolol and Hypercholesterolemia

celiprolol has been researched along with Hypercholesterolemia in 2 studies

Celiprolol: A cardioselective beta-1 adrenergic antagonist that has intrinsic sympathomimetic activity. It is used in the management of ANGINA PECTORIS and HYPERTENSION.

Hypercholesterolemia: A condition with abnormally high levels of CHOLESTEROL in the blood. It is defined as a cholesterol value exceeding the 95th percentile for the population.

Research Excerpts

ExcerptRelevanceReference
"It can be concluded that subjects with moderate hypercholesterolemia and hypertension benefit more from lipid-lowering treatment with simvastatin than from blood pressure-lowering with beta blocker celiprolol."9.12Effects of celiprolol and simvastatin on the calculated risk of coronary heart disease (the Celisimva study). ( Kalliomäki, T; Makkonen, N; Olkinuora, JT; Vanhanen, H; Viikari, J, 2006)
"It can be concluded that subjects with moderate hypercholesterolemia and hypertension benefit more from lipid-lowering treatment with simvastatin than from blood pressure-lowering with beta blocker celiprolol."5.12Effects of celiprolol and simvastatin on the calculated risk of coronary heart disease (the Celisimva study). ( Kalliomäki, T; Makkonen, N; Olkinuora, JT; Vanhanen, H; Viikari, J, 2006)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Olkinuora, JT1
Viikari, J1
Vanhanen, H1
Makkonen, N1
Kalliomäki, T1
Fogari, R1
Zoppi, A1
Corradi, L1
Preti, P1
Mugellini, A1
Lusardi, P1

Trials

2 trials available for celiprolol and Hypercholesterolemia

ArticleYear
Effects of celiprolol and simvastatin on the calculated risk of coronary heart disease (the Celisimva study).
    Scandinavian cardiovascular journal : SCJ, 2006, Volume: 40, Issue:3

    Topics: Aged; Anticholesteremic Agents; Antihypertensive Agents; Celiprolol; Coronary Disease; Drug Therapy,

2006
Beta-blocker effects on plasma lipids during prolonged treatment of hypertensive patients with hypercholesterolemia.
    Journal of cardiovascular pharmacology, 1999, Volume: 33, Issue:4

    Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Analysis of Variance; Atenolol; Bisopr

1999